238 related articles for article (PubMed ID: 21094639)
41. Preconditioning provides complete protection against retinal ischemic injury in rats.
Roth S; Li B; Rosenbaum PS; Gupta H; Goldstein IM; Maxwell KM; Gidday JM
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):777-85. PubMed ID: 9538885
[TBL] [Abstract][Full Text] [Related]
42. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
[TBL] [Abstract][Full Text] [Related]
43. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
[TBL] [Abstract][Full Text] [Related]
44. Expression of mitogen-activated protein kinase family in rat renal development.
Omori S; Hida M; Ishikura K; Kuramochi S; Awazu M
Kidney Int; 2000 Jul; 58(1):27-37. PubMed ID: 10886546
[TBL] [Abstract][Full Text] [Related]
45. In vitro and in vivo neuroprotective effects of cJun N-terminal kinase inhibitors on retinal ganglion cells.
Kim BJ; Silverman SM; Liu Y; Wordinger RJ; Pang IH; Clark AF
Mol Neurodegener; 2016 Apr; 11():30. PubMed ID: 27098079
[TBL] [Abstract][Full Text] [Related]
46. Systemic 7,8-Dihydroxyflavone Treatment Protects Immature Retinas Against Hypoxic-Ischemic Injury via Müller Glia Regeneration and MAPK/ERK Activation.
Huang HM; Huang CC; Tsai MH; Poon YC; Chang YC
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3124-3135. PubMed ID: 30025123
[TBL] [Abstract][Full Text] [Related]
47. Enhanced nitric oxide-mediated autophagy contributes to the hepatoprotective effects of ischemic preconditioning during ischemia and reperfusion.
Shin JK; Kang JW; Lee SM
Nitric Oxide; 2016 Aug; 58():10-9. PubMed ID: 27246638
[TBL] [Abstract][Full Text] [Related]
48. Insulin regulates MAP kinase phosphatase-1 induction in Hirc B cells via activation of both extracellular signal-regulated kinase (ERK) and c-Jun-N-terminal kinase (JNK).
Byon JC; Dadke SS; Rulli S; Kusari AB; Kusari J
Mol Cell Biochem; 2001 Feb; 218(1-2):131-8. PubMed ID: 11330828
[TBL] [Abstract][Full Text] [Related]
49. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
50. Preheating accelerates mitogen-activated protein (MAP) kinase inactivation post-heat shock via a heat shock protein 70-mediated increase in phosphorylated MAP kinase phosphatase-1.
Lee KH; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
J Biol Chem; 2005 Apr; 280(13):13179-86. PubMed ID: 15677475
[TBL] [Abstract][Full Text] [Related]
51. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium.
Fryer RM; Patel HH; Hsu AK; Gross GJ
Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H1184-92. PubMed ID: 11514286
[TBL] [Abstract][Full Text] [Related]
52. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
Reffas S; Schlegel W
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
[TBL] [Abstract][Full Text] [Related]
53. Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury.
Yang CW; Ahn HJ; Jung JY; Kim WY; Li C; Choi BS; Kim HW; Kim YS; Moon IS; Kim J; Bang BK
Transplantation; 2003 Jan; 75(1):20-4. PubMed ID: 12544865
[TBL] [Abstract][Full Text] [Related]
54. The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats.
Budziszewska B; Szymanska M; Leskiewicz M; Basta-Kaim A; Jaworska-Feil L; Kubera M; Jantas D; Lason W
J Physiol Pharmacol; 2010 Apr; 61(2):207-15. PubMed ID: 20436222
[TBL] [Abstract][Full Text] [Related]
55. Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat.
Varano GP; Parisi V; Adornetto A; Cavaliere F; Amantea D; Nucci C; Corasaniti MT; Morrone LA; Bagetta G; Russo R
Mol Vis; 2017; 23():911-921. PubMed ID: 29296071
[TBL] [Abstract][Full Text] [Related]
56. VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration.
Kinney CM; Chandrasekharan UM; Mavrakis L; DiCorleto PE
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C241-50. PubMed ID: 18003751
[TBL] [Abstract][Full Text] [Related]
57. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
[TBL] [Abstract][Full Text] [Related]
58. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38.
Zhao Q; Shepherd EG; Manson ME; Nelin LD; Sorokin A; Liu Y
J Biol Chem; 2005 Mar; 280(9):8101-8. PubMed ID: 15590669
[TBL] [Abstract][Full Text] [Related]
59. Mitogen-activated protein kinase (MAPK) phosphatase-3 (MKP-3) displays a p-JNK-MAPK substrate preference in astrocytes in vitro.
Ndong C; Landry RP; Saha M; Romero-Sandoval EA
Neurosci Lett; 2014 Jul; 575():13-8. PubMed ID: 24861519
[TBL] [Abstract][Full Text] [Related]
60. Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs.
Nieminen R; Korhonen R; Moilanen T; Clark AR; Moilanen E
Arthritis Rheum; 2010 Jun; 62(6):1650-9. PubMed ID: 20178133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
